ClinicaliQ Trial Snapshot
- Barts Sex-CAD Database – Sex Hormones and Inflammatory Status in Coronary Artery Disease — Recruiting • Cardiology / Cardiovascular • NCT06327984.
- What is being tested: The relationship between sex hormones, inflammatory markers, and the development/progression of coronary artery disease (CAD) in women, addressing a significant evidence gap in understanding why CAD presents differently between sexes.
- Patient eligibility overview: The trial recruits individuals with varying CAD status (those with established CAD, at-risk patients, and controls without CAD) to enable comparative analysis of hormonal and inflammatory profiles across disease stages.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
There is a lack of understanding of how Coronary Artery Disease (CAD) - meaning the blocking or furring up of the arteries of the heart - starts and progresses in women. In both men and women, CAD is the most common cause of heart attacks, which occur when the blood supply in the heart is interrupted (these are also known medically as 'acute coronary syndromes'). Before the menopause women appear to be protected from CAD; however, after the menopause that protection is lost. Also, those women who do suffer a…
Eligibility Snapshot
- Any patient presenting with chest pain ≥16 years old presenting to Barts Heart Centre will be included.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.